(Q37822416)

23 August 2017

1 reference

title

Economic and long-term benefits of ribavirin therapy on respiratory syncytial virus infection (English)

1 reference

23 August 2017

1 reference

Snell NJ

1

1 reference

23 August 2017

publication date

1 January 1990

1 reference

23 August 2017

1 reference

23 August 2017

volume

168 Suppl

1 reference

23 August 2017

page(s)

422-429

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02718160

23 August 2017

exact match

0 references

cites work

The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease

1 reference

https://api.crossref.org/works/10.1007%2FBF02718160

Biochemistry and clinical applications of ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02718160

Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency vir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02718160

Respiratory syncytial virus infection and cardiopulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02718160

Effect of ribavirin therapy on respiratory syncytial virus-specific IgE and IgA responses after infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02718160

Continuing respiratory problems three and a half years after acute viral bronchiolitis

21 January 2018

1 reference

12 December 2020

Effects of some viruses on ciliated cells

1 reference

12 December 2020

Aerosolized ribavirin treatment of respiratory syncytial virus infection in infants hospitalized during an epidemic

1 reference

12 December 2020

Respiratory syncytial viral infection in infants with congenital heart disease

1 reference

12 December 2020

Ribavirin aerosol for acute bronchiolitis

1 reference

12 December 2020

Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants

1 reference

12 December 2020

Pulmonary function abnormalities in symptom-free children after bronchiolitis

1 reference

12 December 2020

Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease.

1 reference

12 December 2020

Disturbance in respiratory mechanics in infants with bronchiolitis

1 reference

12 December 2020

Ribavirin treatment of viral pneumonitis in severe combined immunodeficiency disease

1 reference

12 December 2020

Treatment of Respiratory Viral Infection in an Immunodeficient Infant With Ribavirin Aerosol

1 reference

12 December 2020

Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study

1 reference

12 December 2020

Acute respiratory infections and mucociliary clearance

1 reference

12 December 2020

Ribavirin aerosol treatment of influenza

1 reference

12 December 2020

Comparative virulence of respiratory syncytial virus subgroups A and B.

1 reference

12 December 2020

Children's respiratory viral diseases treated with interferon aerosol

1 reference

12 December 2020

Ribavirin aerosol treatment of serious respiratory syncytial virus infection in infants

1 reference

12 December 2020

Nebulised ribavirin for adenovirus pneumonia.

1 reference

12 December 2020

The Tucson Children's Respiratory Study. II. Lower respiratory tract illness in the first year of life

1 reference

12 December 2020

Ribavirin inhibits mast cell mediator release.

1 reference

12 December 2020

Aerosolized ribavirin in the treatment of patients with respiratory syncytial virus disease

1 reference

12 December 2020

Lassa fever. Effective therapy with ribavirin

1 reference

12 December 2020

Release of leukotriene C4 in respiratory tract during acute viral infection

1 reference

12 December 2020

Study of 8-year-old children with a history of respiratory syncytial virus bronchiolitis in infancy

1 reference

12 December 2020

Respiratory syncytial virus and ribavirin

1 reference

12 December 2020

Inhaled steroids and recurrent wheeze after bronchiolitis

1 reference

12 December 2020

Virus-specific IgE and IgG4 antibodies in serum of children infected with respiratory syncytial virus

1 reference

12 December 2020

Acute bronchiolitis in infancy: treatment and prognosis

1 reference

12 December 2020

Prediction of the duration of hospitalization in patients with respiratory syncytial virus infection: use of clinical parameters.

1 reference

12 December 2020

The Development of Respiratory Syncytial Virus-Specific IgE and the Release of Histamine in Nasopharyngeal Secretions after Infection

1 reference

12 December 2020

Ribavirin treatment of experimental respiratory syncytial viral infection. A controlled double-blind study in young adults

1 reference

12 December 2020

The relationship between viral infections and onset of allergic diseases and asthma

1 reference

12 December 2020

Ribavirin in respiratory syncytial virus infection. A double blind placebo controlled trial is needed

1 reference

12 December 2020

Neonatal viral bronchiolitis and pneumonia induces bronchiolar hypoplasia and alveolar dysplasia in rats

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02718160

1 reference

23 August 2017

1 reference